Featured Article

How ICH E6 (R2) Provides a Win/Win/Win through Risk-Based Study Execution

Participant safety is the clinical trial sector’s top priority – and striving to achieve this laudable aim also makes for more agile, flexible and efficient studies.

Guide

NEW: The Ultimate Guide to Modern, Regulatory-Grade RBQM

Download
Blog
The Hidden Inspection Risk in Your Medical and Safety Review Workflow
  • You have just been told an inspection is coming. Your team’s first reaction is not to...
Read More
Blog
Why Medical and Safety Review Is One of the Last Manual Workflows in Clinical Trials
  • It is Tuesday morning. You have a data cut from last night, three studies to review...
Read More
Blog
Turning Oversight into Evidence: How to Prove Your Decisions at Any Point in a Trial
  • Clinical trial oversight is changing. For years, Sponsors have focused on demonstrating that oversight activities occurred:...
Read More
CluePoints RBQM Live25 On-Demand Recordings are now Available! Banner - ROI of RBQM, ICH E6(R3) in Practice, Future of AI